iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Unichem Laboratories has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic? (nebivolol) Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC. Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialized from […]

image

Munish has cited personal reasons and other pre-occupations for his resignation.

image

The unit has manufacturing facilities for the production of kraft paper and duplex paper.

image

Financials stocks were trading in green, with the S&P BSE Finance index increasing 159.05 points or 2.09% at 7761.42 at 09:51 IST.

image

Real Estate stocks were trading in the positive zone, with the S&P BSE Realty Index index rising 66.11 points or 1.97% at 3414.43 at 09:51 IST.

image

Banking stocks were trading with gains, with the S&P BSE BANKEX index rising 768.7 points or 1.92% at 40894.24 at 09:51 IST.

image

EKI Energy Services was locked in 5% upper circuit at Rs 8,151, extending gains for fifth day in a row.

image

The rating on long-term / short-term bank facilities has been reaffirmed at CARE A- (stable outlook) / CARE A2+.

image

Wipro has been positioned as a ‘Leader’ in the Everest Group PEAK Matrix for Intelligent Automation in Healthcare Solutions Provider 2022 report.

image

Wockhardt announced that National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), United States of America (USA) is supporting a Phase 1 clinical trial of Wockhardts novel once-a-day, multidrug-resistant (MDR) Gram-negative targeted antibiotic WCK 6777. The trial will be conducted at NIAIDs Phase I clinical trial units in the USA. NIAID will sponsor the investigational new drug (IND) […]

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.